Jim Cramer sees a ‘second reopening’ of trade in recovery stocks

CNBC’s Jim Cramer delivered an optimistic air on Monday, predicting that reopening coins will rise again when the United States achieves collective immunity against Covid-19.

“If we achieve some sort of herd pseudo-immunity nationwide through a combination of vaccines and infections, or even if we just get a spike in new cases, it could be like a second reopening for stocks of travel, leisure, retail, industrial and energy, ”said the host of“ Mad Money ”.

“Once we start to overcome this new epidemic, they will be the place to invest,” Cramer said, although he offered no stock recommendations.

Cramer credited Dr Scott Gottlieb with helping spark the stock purchase on Monday. Using the UK as an indicator, the Pfizer board member and former head of the US Food and Drug Administration told CNBC he expects delta transmissions in America to reach a peak within a month.

The comments made Cramer more positive about the health outlook.

“When Covid runs out, you’re going to want to own exactly the kind of stocks you would sell if you’re worried about the nightmarish scenario, which is why this market simply refuses to stay low,” Cramer said.

Although Cramer is optimistic that the games will reopen, the market still faces a number of threats, including the increase in Covid cases in the United States due to the highly contagious delta variant and inflation in the United States. Classes. Cramer also included infrastructure talks in Washington, debt ceiling concerns and geopolitical issues with China as other major risks in a “nightmare scenario.”

Disclosure: Scott Gottlieb is a CNBC contributor and serves on the boards of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion Inc., and biotech company Illumina. He is also co-chair of the Healthy Sail Panel of Norwegian Cruise Line Holdings and Royal Caribbean.